Human papillomavirus DNA and p16INK4a expression in hypopharyngeal cancer and in relation to clinical outcome, in Stockholm, Sweden

Oral Oncology

Volumn 51, Issue 9, 2015, Pages 857-861

  Dalianis, Tina ^a   Grün, Nathalie ^a   Koch, Jana ^a   Vlastos, Andrea ^a   Tertipis, Nikolaos ^a   Nordfors, Cecilia ^a   Näsman, Anders ^a   Wendt, Malin ^a   Romanitan, Mircea ^a   Bersani, Cinzia ^a   Munck Wikland, Eva ^a   Ramqvist, Torbjörn ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Disease specific survival; HPV; Hypopharyngeal cancer; Overall survival; P16

Indexed keywords

CETUXIMAB; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DOCETAXEL; FLUOROURACIL; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; HYPOPHARYNX CANCER; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWEDEN; TUMOR BIOPSY; VIRUS EXPRESSION; EPIDEMIOLOGY; HYPOPHARYNX TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PAPILLOMAVIRUS INFECTION; PROGNOSIS; SURVIVAL ANALYSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; SURVIVAL ANALYSIS; SWEDEN;

EID: 84938961731     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2015.06.002     Document Type: Article

References (25)

1. Fact sheets by population. Globocan 2012 Estim Cancer Incid Mortal Prevalence Worldwide 2012. < http://globocan.iarc.fr/Pages/fact-sheets-population.aspx > (accessed 03.06.15).
2. M. Wendt, M. Romanitan, A. Näsman, T. Dalianis, L. Hammarstedt, L. Marklund, and et al. Presence of human papillomaviruses and p16 expression in hypopharyngeal cancer Head Neck 36 2014 107 112 10.1002/hed.23394
3. S.F. Hall, P.A. Groome, J. Irish, and B. O'Sullivan The natural history of patients with squamous cell carcinoma of the hypopharynx Laryngoscope 118 2008 1362 1371 10.1097/MLG.0b013e318173dc4a
4. L. Dal Maso, N. Torelli, E. Biancotto, M. Di Maso, A. Gini, and G. Franchin Combined effect of tobacco smoking and alcohol drinking in the risk of head and neck cancers: a re-analysis of case-control studies using bi-dimensional spline models Eur J Epidemiol 2015 10.1007/s10654-015-0028-3
5. A. Näsman, C. Nordfors, S. Holzhauser, A. Vlastos, N. Tertipis, U. Hammar, and et al. Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: a stabilisation of an epidemic of viral induced carcinoma? Eur J Cancer 51 2015 55 61 10.1016/j.ejca.2014.10.016
6. IARC. Human Papillomaviruses, vol. 90; 2007.
7. P. Attner, J. Du, A. Näsman, L. Hammarstedt, T. Ramqvist, J. Lindholm, and et al. The role of human papillomavirus in the increased incidence of base of tongue cancer Int J Cancer 126 2010 2879 2884 10.1002/ijc.24994
8. L. Dahlgren, H.M. Dahlstrand, D. Lindquist, A. Högmo, L. Björnestål, J. Lindholm, and et al. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients Int J Cancer 112 2004 1015 1019 10.1002/ijc.20490
9. H. Mellin, S. Friesland, R. Lewensohn, T. Dalianis, and E. Munck-Wikland Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival Int J Cancer 89 2000 300 304 10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G [pii]
10. P. Attner, J. Du, A. Näsman, L. Hammarstedt, T. Ramqvist, J. Lindholm, and et al. Human papillomavirus and survival in patients with base of tongue cancer Int J Cancer 128 2011 2892 2897 10.1002/ijc.25625
11. A.C. Nichols, D.A. Palma, S.S. Dhaliwal, S. Tan, J. Theuer, W. Chow, and et al. The epidemic of human papillomavirus and oropharyngeal cancer in a Canadian population Curr Oncol 20 2013 212 219 10.3747/co.20.1375
12. A.M. Hong, A. Martin, M. Chatfield, D. Jones, M. Zhang, B. Armstrong, and et al. Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma Int J Cancer 132 2013 2748 2754 10.1002/ijc.27956
13. M.L. Gillison, W.M. Koch, R.B. Capone, M. Spafford, W.H. Westra, L. Wu, and et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 92 2000 709 720 10.1093/jnci/92.9.709
14. Z. Deng, M. Hasegawa, S. Matayoshi, A. Kiyuna, Y. Yamashita, H. Maeda, and et al. Prevalence and clinical features of human papillomavirus in head and neck squamous cell carcinoma in Okinawa, southern Japan Eur Arch Oto-Rhino-Laryngol 268 2011 1625 1631 10.1007/s00405-011-1515-0
15. M. Hoffmann, T. Görögh, S. Gottschlich, C. Lohrey, W. Rittgen, P. Ambrosch, and et al. Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients Cancer Lett 218 2005 199 206 10.1016/j.canlet.2004.09.027
16. S. Sethi, R. Ali-Fehmi, S. Franceschi, L. Struijk, L.J. Van Doorn, W. Quint, and et al. Characteristics and survival of head and neck cancer by HPV status: a cancer registry-based study Int J Cancer 131 2012 1179 1186 10.1002/ijc.26500
17. J.P. Rodrigo, M.A. Hermsen, M.F. Fresno, R.H. Brakenhoff, F. García-Velasco, P.J.F. Snijders, and et al. Prevalence of human papillomavirus in laryngeal and hypopharyngeal squamous cell carcinomas in northern Spain Cancer Epidemiol 39 2015 37 41 10.1016/j.canep.2014.11.003
18. P. Ernoux-Neufcoeur, M. Arafa, C. Decaestecker, A. Duray, M. Remmelink, X. Leroy, and et al. Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma J Cancer Res Clin Oncol 137 2011 173 181 10.1007/s00432-010-0871-2
19. G. Pannone, V. Rodolico, A. Santoro, L. Lo Muzio, R. Franco, G. Botti, and et al. Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization Infect Agent Cancer 7 2012 4 10.1186/1750-9378-7-4
20. D. Lindquist, M. Romanitan, L. Hammarstedt, A. Näsman, H. Dahlstrand, J. Lindholm, and et al. Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7 Mol Oncol 1 2007 350 355 10.1016/j.molonc.2007.08.005
21. S.J. Smeets, A.T. Hesselink, E.-J.M. Speel, A. Haesevoets, P.J.F. Snijders, M. Pawlita, and et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen Int J Cancer 121 2007 2465 2472 10.1002/ijc.22980
22. F. Bussu, M. Sali, R. Gallus, G. Petrone, G.F. Zannoni, R. Autorino, and et al. Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators - a pilot study Int J Radiat Oncol Biol Phys 89 2014 1115 1120 10.1016/j.ijrobp.2014.04.044
23. L. Hammarstedt, D. Lindquist, H. Dahlstrand, M. Romanitan, L.O. Dahlgren, J. Joneberg, and et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer Int J Cancer 119 2006 2620 2623 10.1002/ijc.22177
24. C. Nordfors, A. Vlastos, J. Du, A. Ährlund-Richter, N. Tertipis, N. Grün, and et al. Human papillomavirus prevalence is high in oral samples of patients with tonsillar and base of tongue cancer Oral Oncol 50 2014 491 497 10.1016/j.oraloncology.2014.02.012
25. C. Ndiaye, M. Mena, L. Alemany, M. Arbyn, X. Castellsagué, L. Laporte, and et al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis Lancet Oncol 15 2014 1319 1331 10.1016/S1470-2045(14)70471-1